NASDAQ:IDRA   Idera Pharmaceuticals, Inc
IDERA :

Croissance de 72% p/a - deux traitement anti-cancéreux du colon en cours phase 2 & 3.

IDERA:

Growth of 72% p / a - Two anti-cancer treatments for the colon in phase 2 & 3

https://finance.yahoo.com/news/idera-pha...